We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

111 hedge funds and large institutions have $266M invested in GenMark Diagnostics, Inc in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 28

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

1% more funds holding

Funds holding: 110 → 111 (+1)

17% less capital invested

Capital invested by funds: $320M → $266M (-$53.9M)

Holders
111
Holders Change
+1
Holders Change %
+0.91%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
49
Reduced
28
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.79M
2
NIM
Needham Investment Management
New York
+$3.01M
3
Bank of America
Bank of America
North Carolina
+$2.35M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.04M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.89M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$2.49M
3
Millennium Management
Millennium Management
New York
-$1.86M
4
MAG
Millrace Asset Group
Pennsylvania
-$1.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
BAM
51
Bullseye Asset Management
Colorado
$381K +$437K +79,272 New
Russell Investments Group
52
Russell Investments Group
United Kingdom
$376K +$253K +45,929 +141%
Los Angeles Capital Management
53
Los Angeles Capital Management
California
$359K – – –
Man Group
54
Man Group
United Kingdom
$337K -$139K -25,200 -26%
WI
55
WrapManager Inc
California
$328K +$22K +3,992 +6%
Envestnet Asset Management
56
Envestnet Asset Management
Illinois
$316K +$37.5K +6,798 +12%
AllianceBernstein
57
AllianceBernstein
Tennessee
$314K – – –
DCM
58
Donaldson Capital Management
Indiana
$303K – – –
Ameriprise
59
Ameriprise
Minnesota
$273K +$86.1K +15,614 +38%
UBS AM
60
UBS AM
Illinois
$264K -$7.94K -1,440 -3%
William Blair & Company
61
William Blair & Company
Illinois
$227K -$163K -29,550 -38%
Baird Financial Group
62
Baird Financial Group
Wisconsin
$227K – – –
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$223K – – –
AQR Capital Management
64
AQR Capital Management
Connecticut
$209K -$455K -82,446 -66%
LOAMU
65
Lombard Odier Asset Management (USA)
New York
$206K +$43.7K +7,920 +23%
PP
66
PDT Partners
New York
$204K +$35.9K +6,500 +18%
HSBC Holdings
67
HSBC Holdings
United Kingdom
$197K -$202K -36,561 -47%
BBVA
68
Banco Bilbao Vizcaya Argentaria
Spain
$192K +$221K +40,000 New
ONB
69
Old National Bancorp
Indiana
$183K – – –
EGM
70
Engineers Gate Manager
New York
$180K +$30.1K +5,459 +17%
AIG
71
American International Group
New York
$167K +$1.89K +342 +1%
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$166K -$9.42K -1,707 -5%
EMG
73
ETF Managers Group
New Jersey
$166K +$44.3K +8,024 +30%
Commonwealth Equity Services
74
Commonwealth Equity Services
Massachusetts
$162K +$66.2K +12,000 +55%
PTC
75
Petrus Trust Company
Texas
$154K +$176K +31,953 New
1 2
3
4 5

GNMK Hedge Fund Activity: Q4 2019 in Review

111 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2019, worth a combined $266M — down 17% from $320M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 49 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.79M. The largest seller was T. Rowe Price Associates, cutting an estimated $4.89M.

  • 111 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2019, up from 110 in Q3 2019.
  • Funds reported $266M of GenMark Diagnostics, Inc stock for Q4 2019, down 17% quarter-over-quarter.
  • 10 funds opened new GenMark Diagnostics, Inc positions in Q4 2019 and 9 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2019 was Morgan Stanley, an estimated $5.79M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2019 was T. Rowe Price Associates, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2019.